
|Videos|September 26, 2016
The Impact of Limited Distribution Networks on Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
3
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
4
A First-of-Its-Kind All-Oral Option Receives FDA Approval for Newly Diagnosed AML
5

































































































































